Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
0.9510
+0.0113 (1.20%)
At close: May 23, 2025, 4:00 PM
0.9394
-0.0116 (-1.22%)
After-hours: May 23, 2025, 7:29 PM EDT
Moleculin Biotech Employees
Moleculin Biotech had 17 employees as of December 31, 2024. The number of employees decreased by 1 or -5.56% compared to the previous year.
Employees
17
Change (1Y)
-1
Growth (1Y)
-5.56%
Revenue / Employee
n/a
Profits / Employee
-$1,366,412
Market Cap
13.31M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
MBRX News
- 9 days ago - Moleculin Biotech, Inc. (MBRX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Moleculin Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 11 days ago - Moleculin Receives European Medicines Agency Approval to Expand Phase 3 MIRACLE Clinical Trial - GlobeNewsWire
- 16 days ago - Moleculin to Report First Quarter 2025 Financial Results on May 13, 2025 and Host Conference Call and Webcast - GlobeNewsWire
- 17 days ago - Moleculin Announces World Health Organization Approval of “naxtarubicin” as International Non-Proprietary Name for Annamycin - GlobeNewsWire
- 18 days ago - Moleculin Bolsters Annamycin Intellectual Property Portfolio with Granting of Two New U.S. Patents - GlobeNewsWire
- 24 days ago - Moleculin Announces New Pre-Clinical Data for Annamycin Demonstrating Market Expansion Potential Including Treatment for Pancreatic Cancer - GlobeNewsWire
- 5 weeks ago - Moleculin Announces Acceptance of Abstract to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 - GlobeNewsWire